Fig. 3From: Loss of NPM2 expression is a potential immunohistochemical marker for malignant peritoneal mesothelioma: a single-center study of 92 casesSurvival analysis. A Overall survival. B NPM2 protein expression. C Karnofsky performance status score. D Increased preoperative tumor markers (any one of carcinoembryonic antigen, carbohydrate antigen (CA) 19-9, CA 125, and alpha-fetoprotein was increased). E Ascites. F Red blood cell infusion. G Ki-67. H Vascular tumor emboli. I Serious adverse eventsBack to article page